News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Legal Fight Over Myriad Genetics, Inc. Breast Cancer Gene Begins
June 9, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
CBC News -- Landmark legal action challenging a patent over breast cancer gene BRCA1 is being launched in Australia Tuesday. The Australian action follows a lawsuit in the United States against patent holder Myriad Genetics.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Asia
Australia
MORE ON THIS TOPIC
Layoffs
WARN Act 101: How It Actually Works
August 14, 2025
·
5 min read
·
Angela Gabriel
Tariffs
Trump Tarries on Tariffs Again, Delays Plans by Weeks: Report
August 14, 2025
·
2 min read
·
Tristan Manalac
PODCAST
The Hidden Patent Crisis That Could Break Biotech: What Every CEO Needs to Know
August 14, 2025
·
1 min read
·
Lori Ellis
Legal
Texas Accuses Lilly of ‘Bribing’ Prescribers To Push Mounjaro, Zepbound in New Suit
August 13, 2025
·
2 min read
·
Tristan Manalac
